Skip to product information
1 of 1

Cloud-clone

SKU:RPL643Hu01

Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7)

Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7)

Regular price $446.00 USD
Regular price Sale price $446.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Purity
Organism species

Prokaryotic expression

Product No.

RPL643Hu01

Organism Species

Homo sapiens (Human)

Source

Prokaryotic expression

Host

E.coli

Endotoxin Level

<1.0EU per 1µg (determined by the LAL method)

Subcellular Location

Secreted, Extracellular matrix

Predicted Molecular Mass

30.8kDa

Accurate Molecular Mass

31kDa(Analysis of differences refer to the manual)

Residues & Tags

Tyr24~Ser273 with N-terminal His Tag

Buffer Formulation

20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

Traits

Freeze-dried powder

Purity

> 95%

Isoelectric Point

8.3

Applications

Positive Control; Immunogen; SDS-PAGE; WB.

If bio-activity of the protein is needed, please check active protein.



UOM

10µg 50µg 200µg 1mg 5mg

SEQUENCE

 

 

 

USAGE

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine Citations
Scientific Reports Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab PMC5443778
Scientific Reports Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. pubmed:28539619
International Journal of Clinical and Experimental Pathology EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells ISSN:1936-2625
Cancer Drug Resist MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPL643Hu01 Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7) Positive Control; Immunogen; SDS-PAGE; WB.
PAL643Hu01 Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7) WB; IHC; ICC; IP.
MAL643Hu21 Monoclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7) WB; IHC; ICC; IP.
SEL643Hu ELISA Kit for EGF Like Domain Protein, Multiple 7 (EGFL7) Enzyme-linked immunosorbent assay for Antigen Detection.
LML643Hu Magnetic Luminex Assay Kit for EGF Like Domain Protein, Multiple 7 (EGFL7) ,etc. Magnetic Luminex Assay for Antigen Detection.
PGL643Hu01 Primer Pair for EGF Like Domain Protein, Multiple 7 (EGFL7) PCR
View full details